Accounts Payable and Accrued Expenses

6 Months Ended

12 Months Ended

Nov. 30, 2025

Dec. 31, 2025

May 31, 2025

Accounts Payable and Accrued Expenses [Line Items]

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

10. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses as of December 31, 2025 and 2024 consisted of:

		December 31, 2025			December 31, 2024
Research and development expenses payable		$	830,189		$	778,205
Professional fees payable			185,247			127,031
Others			56,279			13,375
		$	1,071,715		$	918,611

DiamiR Biosciences Corp. [Member]

Accounts Payable and Accrued Expenses [Line Items]

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 7 — ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following:

		November 30, 2025			May 31, 2025
Outside services		$	643,784		$	220,411
Employee compensation			19,248			5,884
Other			10,364			5,563
Total		$	673,396		$	231,858

NOTE 7 — ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following:

		May 31, 2025			May 31, 2024
Outside services		$	220,411		$	123,065
Employee compensation			5,884			12,285
Other			5,563			13,298
Total		$	231,858		$	148,648